"By enabling researchers to systematically investigate the molecular pathways that drive cancer growth, resistance, and immune evasion, CRISPR is contributing to advances in drug development strategies. With its unparalleled precision and adaptability to large experimental designs, CRISPR allows researchers to perform genome-wide functional screens that can accelerate the development of precision cancer therapies in ways not previously possible. These findings demonstrate how CRISPR technologies can be used to bridge basic discovery and actionable clinical insight to accelerate cancer drug development."